Empty Hard Gelatin Capsules Market to Reach $5.7 Billion by 2035

Empty hard gelatin capsules market was valued at $3.3 billion in 2025 and is projected to reach $5.7 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). The growth of the empty hard gelatin capsules market is fundamentally supported by the sustained expansion of oral solid dosage manufacturing across the pharmaceutical industry. According to data referenced by the Brookings Institution, approximately 187 billion tablets and capsules were dispensed in the US in 2024, reflecting the scale at which solid dosage forms are consumed in regulated markets. This high-volume consumption directly translates into continuous demand for capsule shells as a primary delivery format. In addition, oral solid dosage formulations account for a significant share of drug delivery systems due to their ease of administration, stability, and cost efficiency. Government regulatory bodies such as the US Food and Drug Administration maintain strict oversight of drug quality and manufacturing practices, reinforcing the widespread use of standardized dosage forms such as capsules. The presence of a large installed base of manufacturing facilities further supports production scalability and consistent procurement of capsule shells.

Browse the full report description of “Empty Hard Gelatin Capsules Market Size, Share & Trends Analysis Report by Product Type (Bovine Source Gelatin, Fish Source Gelatin, Porcine Gelatin, and Others), by End-User (Pharmaceutical Companies, Nutraceutical Companies, Contract Manufacturing Organizations (CMOs), and Research & Academic Institutes), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/empty-hard-gelatin-capsules-market

The structural shift toward generic drug manufacturing and large-scale pharmaceutical production continues to strengthen this demand pattern. Regulatory data from the US Food and Drug Administration indicate that a significant share of finished dosage manufacturing facilities are globally distributed, supporting high-output production of tablets and capsules. This distributed manufacturing ecosystem enables continuous, high-volume utilization of capsule shells across multiple regions. Furthermore, increasing healthcare access and long-term treatment regimens are contributing to sustained consumption of solid dosage medications, reinforcing recurring demand cycles. The scalability of capsule-based drug delivery aligns with bulk manufacturing requirements, particularly in generic and over-the-counter drug segments. As pharmaceutical companies continue to prioritize efficient, standardized dosage formats, the reliance on empty hard gelatin capsules remains structurally embedded within production systems, supporting long-term market expansion.

Innovation Leaders Transforming the Empty Hard Gelatin Capsules Market

The key players in the empty hard gelatin capsules market include Lonza Group (Capsugel brand), ACG Worldwide, Qualicaps, Suheung Co Ltd, CapsCanada Corp., among others. These companies are advancing innovation in empty hard gelatin capsules through the development of high-precision capsule manufacturing technologies, enhanced material processing techniques, and scalable high-speed production systems, enabling consistent quality, improved dissolution performance, and reliable supply for pharmaceutical and nutraceutical applications while supporting increasing demand for efficient and standardized oral dosage delivery formats.

• In June 2025, ACG commenced operations at a new empty hard gelatin capsule manufacturing facility in Rayong, Thailand. The plant is designed to produce up to 20 billion capsules annually and will serve key markets across Asia, including Southeast Asia and South Korea. The facility strengthens ACG’s regional supply chain and improves distribution efficiency. It also incorporates advanced capsule printing technology and is expected to support future expansion into the Chinese market.

• In June 2023, PSK Pharma started manufacturing empty hard gelatin capsules under its PHARMCAPS brand, marking its entry into capsule production. The initiative aligns with Russia’s Pharma-2030 strategy, which focuses on reducing reliance on imports and strengthening domestic pharmaceutical capabilities.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Lonza Group (Capsugel brand), ACG Worldwide, Qualicaps, Suheung Co Ltd, CapsCanada Corp., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Empty Hard Gelatin Capsules Market Report Segment

By Product Type

• Bovine Source Gelatin
• Fish Source Gelatin
• Porcine Gelatin
• Others

By End-User

• Pharmaceutical Companies
• Nutraceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Research & Academic Institutes

Global Empty Hard Gelatin Capsules Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/empty-hard-gelatin-capsules-market